MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-18-2026
Koninklijke Philips N.V. Cash Conversion Cycle 2011-2026 | PHG
Annual Cash Conversion Cycle Koninklijke Philips N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 89 | 87.9 | 91.7 | 86.7 | 82.9 | 95 |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 95 | 82.9 | 88.9 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Burning Rock Biotech Limited
BNR
|
149 | $ 16.79 | -2.33 % | $ 181 M |  China |
 |
CareDx, Inc
CDNA
|
51.5 | $ 20.96 | - | $ 1.12 B |  USA |
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
-2.46 K | $ 1.6 | 1.91 % | $ 2.13 M | USA |
 |
Castle Biosciences
CSTL
|
45.9 | $ 24.98 | -2.14 % | $ 694 M | USA |
 |
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
42.4 | $ 14.61 | -3.37 % | $ 442 M | USA |
 |
Agilent Technologies
A
|
111 | $ 115.92 | 3.45 % | $ 35.2 B | USA |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
62 | $ 113.13 | 1.04 % | $ 9.33 B |  Irlanda |
 |
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
Lantheus Holdings
LNTH
|
97.3 | $ 86.87 | -1.04 % | $ 5.86 B | USA |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
142 | $ 137.52 | -1.33 % | $ 21.9 B | USA |
 |
Myriad Genetics
MYGN
|
49.3 | $ 4.95 | 0.1 % | $ 458 M | USA |
 |
NeoGenomics
NEO
|
82.4 | $ 8.95 | -0.56 % | $ 1.15 B | USA |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
29.4 | $ 18.52 | 1.65 % | $ 415 M | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 421.13 | 0.99 % | $ 12.1 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 175.79 | 2.0 % | $ 8.71 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
Personalis
PSNL
|
-11.5 | $ 5.76 | -2.46 % | $ 341 M | USA |
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
79.6 | $ 89.53 | -1.8 % | $ 11.2 B | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Interpace Biosciences
IDXG
|
62.9 | $ 2.0 | -5.66 % | $ 8.85 M | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 465.11 | 0.56 % | $ 175 B | USA |
 |
Senseonics Holdings
SENS
|
36.1 | $ 4.86 | -2.99 % | $ 203 M | USA |
 |
Soleno Therapeutics
SLNO
|
-398 | $ 52.92 | 0.03 % | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
83.6 | $ 58.02 | 3.25 % | $ 3.47 B | USA |
 |
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B |  Niderland |
 |
Biomerica
BMRA
|
172 | $ 2.19 | 1.38 % | $ 5.03 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 254.31 | 0.52 % | $ 21.2 B | USA |
 |
Natera
NTRA
|
81.5 | $ 210.69 | -0.41 % | $ 20.7 B | USA |
 |
Neogen Corporation
NEOG
|
150 | $ 9.28 | 2.04 % | $ 2.01 B | USA |
 |
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 190.85 | -0.38 % | $ 21.2 B | USA |
 |
Waters Corporation
WAT
|
731 | $ 338.34 | 12.22 % | $ 20.1 B | USA |